Skip to content Skip to footer

press releases

press releases

SMURF-Therapeutics, Inc.

DEC 21st, 2023 Poster Presentation at Annual AACR

DEC 21st, 2023 Appointments to Leadership Team at Smurf Therapeutics

DEC 21st, 2023 Publication of Smurf's Interaction with HIF

DEC 21st, 2023 Poster Presentation at Annual AACR

PRESS RELEASES

Dr. Emile Youssef appointed Chief Medical Officer at SMURF-Therapeutics, Inc.

Jan292024
Time: 12:00 am
Picture4

SMURF-Therapeutics, Inc. Announces Six New Appointments to Scientific Advisory Board

Dec12023
Time: 12:00 am - 12:00 am
Picture

EVENTS & PRESENTATIONS

Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance.

Jul182023
Time: 12:00 am - 12:00 am
thumbnail

SMURF-2 data in 2023 AACR Poster Presentation

Apr152023
Time: 12:00 am - 12:00 am
thumbnail

IN THE NEWS

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation: Molecular Cell

Dec72023
Time: 12:00 am - 12:00 am
thumbnail
Go to Top